COVID-19 connected to dementia-like disability, multiple studies find
By
Alicia Lasek
Jul 27, 2021
A bout with COVID-19 can cause dementia-like brain changes and related functional decline, especially for seniors and in people who lose their sense of smell, researchers are finding.
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Criticism, confusion and hope: new Alzheimer’s drug receives messy welcome
By
Alicia Lasek
Jun 15, 2021
Clinicians’ responses to the controversial approval of Aduhelm range between excitement and disapproval, with questions abounding on how to advise patients on treatment and the cost to patients and...